VanEck Associates’s Hanover Insurance THG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-4,197
Closed -$539K 1462
2023
Q1
$539K Buy
4,197
+3,102
+283% +$417K ﹤0.01% 993
2022
Q4
$148K Buy
1,095
+85
+8% +$11.9K ﹤0.01% 1170
2022
Q3
$129K Buy
1,010
+91
+10% +$12.3K ﹤0.01% 1133
2022
Q2
$134K Buy
919
+24
+3% +$3.52K ﹤0.01% 1158
2022
Q1
$134K Buy
895
+123
+16% +$17.2K ﹤0.01% 1175
2021
Q4
$101K Buy
772
+62
+9% +$8.04K ﹤0.01% 1246
2021
Q3
$92K Buy
710
+264
+59% +$36K ﹤0.01% 1166
2021
Q2
$60K Buy
446
+253
+131% +$34.7K ﹤0.01% 1182
2021
Q1
$25K Buy
+193
New +$23.3K ﹤0.01% 1165

Other funds holding THG

VanEck Associates's THG Position: Q2 2023 in Review

VanEck Associates sold out of Hanover Insurance (THG) in Q2 2023, closing a stake of 4,197 shares — an estimated $539K sold.

VanEck Associates first reported a position in THG in Q1 2021 and held it in 9 quarters. The position peaked at $539K in Q1 2023. 336 funds tracked by Wall St. Rank hold THG as of Q2 2023.

  • VanEck Associates reported no remaining Hanover Insurance position as of Q2 2023 after selling out during the quarter.
  • VanEck Associates sold 4,197 Hanover Insurance shares in Q2 2023, an estimated $539K.
  • VanEck Associates first reported a position in Hanover Insurance in Q1 2021 and held it in 9 quarters.
  • VanEck Associates's Hanover Insurance position peaked at $539K in Q1 2023.
  • 336 funds tracked by Wall St. Rank held Hanover Insurance as of Q2 2023.

Based on VanEck Associates's 13F filing for Q2 2023, filed 3 Aug 2023.